Upcoming speakers

Previous speakers

6 May
Charles Keller
Children's Cancer Therapy Development Institute  

Machine Learning for rhabdomyosarcoma subtype diagnosis (a research study with international aspirations)

Twitter: @cctdilab 

13 May
Joshua Waterfall
Institut Curie

Deep learning and transcriptomic profiling for sarcoma diagnosis

Twitter: @joshwaterfall 

18 May
Brian Van Tine
Washington University in St. Louis

Sarcoma Metabolism

Please note this webinar is on a Monday

Twitter: @bvantine1 

27 May
David Kirsch   
Duke University

Opportunities and challenges of using immunotherapy in soft tissue sarcomas

Twitter: @DKirschMDPhD 

5 June
Kevin Jones
Huntsman Cancer Institute

The genetics of translocation-associated sarcomagenesis

Please note this webinar is on a Friday

10 June
David Drewry
University of North Carolina at Chapel Hill

Drug Discovery strategies for Chordoma: Vulnerability identification and vulnerability targeting

Twitter: @dhdrewry

17 June
Corrie Painter
Broad Institute

The Angiosarcoma Project

Twitter: @corrie_painter 

1 July
Matthew Blackledge
The Institute of Cancer Research

Artificial Intelligence and quantitative imaging: a new paradigm for sarcoma response assessment?

Twitter: @blackledgeICR 

8 July
Thomas Grünewald
German Cancer Research Center

Targeting developmental pathways in Ewing sarcoma

Twitter: @GrunewaldLab

13 July
Nischalan Pillay
University College London Cancer Institute

The copy number signature landscape of sarcomas

Please note this webinar is on a Monday

Twitter: @NischalanP

22 July
Jacob Scott
Cleveland Clinic - Learner Research Institute

Identifying states of collateral sensitivity during the evolution of therapeutic resistance in Ewing’s sarcoma using experimental evolution and mathematical modeling

Twitter: @CancerConnector

29 July
Javed Khan
National Cancer Institute

Exploring and targeting the epigenome of fusion positive rhabdomyosarcoma

Twitter: @khanjavNCI

5 August
Jesse Boehm
Broad Institute

Systematic approaches to create and perturb patient-derived models of rare tumors

Twitter: @boehmjesse

12 August
Angela Hirbe
Washington University in St. Louis

Advancing therapy for NF1 and sporadic MPNST: The role of genomics and novel models

17 August
Judith Bovée
Leiden University

Sarcoma modeling for patient specific treatment

Please note this webinar is on a Monday

26 August
Sebastian Bauer
Universitätsklinikum Essen

TKI-resistance in KIT/PDGFRA-mutant GIST – molecular mechanisms and implications for salvage treatments

Twitter: @seppobauer

9 September
Matthew Hemming
Dana-Farber Cancer Institute

Anatomic and transcriptional determinants of gastrointestinal stromal tumour

16 September
Paul Huang
The Institute of Cancer Research

Optimising kinase inhibitor therapy in soft tissue sarcomas

Twitter: @HuanglabICR 

23 September
Benjamin Nacev
Memorial Sloan Kettering Cancer Center

Histone mutations in sarcomas and other cancers

Twitter: @BenNacev

30 September
Ana Banito
German Cancer Research Center

Mechanistic insights into SS18-SSX-driven synovial sarcoma 

Twitter: @SoftSarcoma

7 October
Wolf Fridman
Cordeliers Research Centre, INSERM

B cells and Tertiary Lymphoid Structures predict survival and immunotherapy response in Soft Tissue Sarcoma

14 October
Vivek Subbiah
MD Anderson Cancer Center

Precision Oncology in Sarcomas: Divide and Conquer 

Twitter: @VivekSubbiah

21 October
Agnieszka Wozniak
Katholieke Universiteit Leuven

The XenoSarc Platform

Twitter: @AgaWozniak1

28 October
Sophie Postel-Vinay
Institut Gustave Roussy

Insights into Desmoplastic Small Round Cell Tumour biology through single cell sequencing

4 November
Torsten Nielsen
University of British Columbia

Sarcoma molecular diagnostics - the new generation of techniques entering clinical practice

11 November
Priya Chudasama
German Cancer Research Center
National Center for Tumor Diseases, Heidelberg

Molecular mechanisms and drug targets in Leiomyosarcoma

Twitter: @priyachudasama5